Atezolizumab-induced anaphylactic shock in a patient with hepatocellular carcinoma undergoing immunotherapy: A case report

doi:10.12998/wjcc.v9.i16.4110

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5718)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

379

WORD

139

HTML

3390

Figures (1-1)

331

Sum=4239

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

458

Download

1021

Sum=1479

Jun 6, 2021 (publication date) through Nov 19, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jun 6, 2021; 9(16): 4110-4115
Published online Jun 6, 2021. doi: 10.12998/wjcc.v9.i16.4110

Open in New Tab Full Size Figure Download Figure

Figure 1 Abdominal contrast-enhanced computed tomography at 1. 5 years after right radical hepatectomy. A: Computed tomography showed multiple recurrences of intrahepatic tumors; B: Computed tomography showed invasion of the inferior vena cava and the right branch of the portal vein; C: Computed tomography showed tumor thrombus formation in the inferior vena cava and left atrium.

Citation: Bian LF, Zheng C, Shi XL. Atezolizumab-induced anaphylactic shock in a patient with hepatocellular carcinoma undergoing immunotherapy: A case report. World J Clin Cases 2021; 9(16): 4110-4115
URL: https://www.wjgnet.com/2307-8960/full/v9/i16/4110.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i16.4110